levetiracetam and Graves-Disease

levetiracetam has been researched along with Graves-Disease* in 1 studies

Other Studies

1 other study(ies) available for levetiracetam and Graves-Disease

Article	Year
[Diagnosis of Graves' disease by cerebral venous thrombosis: a case report]. Rinsho shinkeigaku = Clinical neurology, 2018, Nov-28, Volume: 58, Issue:11 A 71-year-old male with no previous medical history was admitted to our hospital for paralysis of the right upper extremity. Although DWI of the brain revealed high-intensity signals in the bilateral frontal and left parietal lobes, CT revealed a hyperdense spot in the anterior superior sagittal sinus (SSS). Because CT venography revealed SSS occlusion, he was diagnosed with cerebral venous thrombosis (CVT). In addition, laboratory findings, including free triiodothyronine, 8.85 pg/ml; thyroxine, 3.39 pg/dl, thyroid-stimulating hormone (TSH), < 0.02 μU/ml; and anti-TSH receptor antibody, 5.7 IU/l, led to the diagnosis of hyperthyroidism for the first time. Moreover, factor VIII procoagulant protein levels exhibited a marked increase (187.5%). Based on these findings, the patient was diagnosed with CVT due to Graves' disease. Topics: Aged; Antithyroid Agents; Autoantibodies; Factor VIII; Graves Disease; Heparin; Humans; Intracranial Thrombosis; Levetiracetam; Magnetic Resonance Imaging; Male; Methimazole; Phlebography; Receptors, Thyrotropin; Tomography, X-Ray Computed; Treatment Outcome	2018

Article

Year

[Diagnosis of Graves' disease by cerebral venous thrombosis: a case report].

Rinsho shinkeigaku = Clinical neurology, 2018, Nov-28, Volume: 58, Issue:11

A 71-year-old male with no previous medical history was admitted to our hospital for paralysis of the right upper extremity. Although DWI of the brain revealed high-intensity signals in the bilateral frontal and left parietal lobes, CT revealed a hyperdense spot in the anterior superior sagittal sinus (SSS). Because CT venography revealed SSS occlusion, he was diagnosed with cerebral venous thrombosis (CVT). In addition, laboratory findings, including free triiodothyronine, 8.85 pg/ml; thyroxine, 3.39 pg/dl, thyroid-stimulating hormone (TSH), < 0.02 μU/ml; and anti-TSH receptor antibody, 5.7 IU/l, led to the diagnosis of hyperthyroidism for the first time. Moreover, factor VIII procoagulant protein levels exhibited a marked increase (187.5%). Based on these findings, the patient was diagnosed with CVT due to Graves' disease.

Topics: Aged; Antithyroid Agents; Autoantibodies; Factor VIII; Graves Disease; Heparin; Humans; Intracranial Thrombosis; Levetiracetam; Magnetic Resonance Imaging; Male; Methimazole; Phlebography; Receptors, Thyrotropin; Tomography, X-Ray Computed; Treatment Outcome

2018